Cooley Partner Joins Biotechnology Innovation Organization’s Board of Directors
Sonia Nath, Cooley partner and chair of the firm’s global life sciences and healthcare regulatory practice group, was appointed to the Emerging Companies Section Governing Board of the Biotechnology Innovation Organization (BIO), an advocacy association that represents the biotech industry.
BIO has a Board Executive Committee and three section governing boards organized by industrial sector and policy interest – the Emerging Companies Section (ECS) Governing Board, the Agriculture & Environment (A&E) Section Governing Board and the Health Section Governing Board. These boards are comprised of thought leaders who bring experience to bear on major issues affecting their specific area of the biotechnology industry.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.